Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis. - Wikidata - awgldk - TriplyDB

Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.

Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q33667694

about

Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome.Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.

P2860

Q40067064-CA56F7FD-A48A-4EB5-9DEF-26F8A6203561 Q47133516-798FEBF3-874E-4653-95EA-B083C16639B4 Q48341665-FEED523F-972F-4A52-97A8-45C21A17CAC5

P2860

Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q33667694

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Is hydroxychloroquine effectiv ...... atic review and meta-analysis.

@ast

Is hydroxychloroquine effectiv ...... atic review and meta-analysis.

@en

type

label

Is hydroxychloroquine effectiv ...... atic review and meta-analysis.

@ast

Is hydroxychloroquine effectiv ...... atic review and meta-analysis.

@en

prefLabel

Is hydroxychloroquine effectiv ...... atic review and meta-analysis.

@ast

Is hydroxychloroquine effectiv ...... atic review and meta-analysis.

@en

P1433

Q33667694-E3274C3B-6EB2-4C09-A76B-73478ACE376A

P1476

Q33667694-363ADF30-186D-408E-97C5-3499CFCE0C20

P2093

Q33667694-8AB9C8CC-0DB8-4D2B-9C59-CEB86FD3EE0C

Q33667694-98329607-DECF-4AA5-BF2B-155386987FB6

Q33667694-C5E1EEBA-A9F6-4A10-8E3C-7335E751EDB9

Q33667694-C95828FB-07EE-4E19-8D97-9495EAB9BE75

P275

Q33667694-FE4356BF-D52B-4D14-A65A-B5AD117ECA6E

P2860

Q33667694-0CA2ADC0-1BCA-4BF9-B920-048426C466FD

Q33667694-11BA05B0-1FFB-4BD5-94BC-EE103722D532

Q33667694-11E59B1B-1040-4BAD-BED2-DFEEB7B57372

Q33667694-19F0715C-CFF2-481F-8077-BE0BA28FA4BA

Q33667694-2C6FD00A-675C-4165-8AD5-0925F084D95A

Q33667694-2CCC20B8-16B9-4F99-AE9A-C064A938816D

Q33667694-31F20C95-7A0F-44E4-9119-C4351681E4E2

Q33667694-35CDEA76-B66B-409C-A34C-28F6F56BF457

Q33667694-380A1239-F4B4-456B-8F6D-A01564A78E59

Q33667694-3A1F6F30-5008-4334-92B8-66CB8D485917

P2888

Q33667694-D9124930-0B4A-4B3E-97E5-70F1F52635FE

P304

Q33667694-2FE05B03-F92F-472D-A0CC-E83EA683801A

P31

Q33667694-4a4c04f3-2ee1-494b-9fc4-30bd44f4d2e7

Q33667694-8AE8AD08-4211-4FB0-B6EB-72FF40E3EBFE

Q33667694-F148A829-EFC1-4D27-B664-986F7D4FF456

P356

Q33667694-06D1FCE0-4593-473F-A59F-7701AE5758D1

P433

Q33667694-8A6192C3-1C48-4E5F-A268-E59B1EFFFE5E

P478

Q33667694-AC14D117-0E9D-4A5B-9F3B-8022FF4E0813

P5008

Q33667694-7BDFBEEB-2ECE-47A5-8908-36B48CF9282B

P577

Q33667694-7CEB17DA-B066-4C6D-9092-A9F98EAE6824

P6179

Q33667694-25CF6E41-7793-427D-83D3-B1E3760A0DFC

P698

Q33667694-F10BF6B0-9B88-4936-BD29-F16901FA1787

P921

Q33667694-0572894E-75CD-4C1A-91E2-C5E0BBAE7A7F

Q33667694-6D3212DC-1FD4-4E8D-80E5-C1B5F21B3AA1

Q33667694-E9771965-8F62-460D-AF49-16707F81813E

P932

Q33667694-E2A8AAB5-E6B9-441A-892F-CE7C46565CF6

P356

S12891-017-1543-Z

P1433

BMC Musculoskeletal Disorders

P1476

Is hydroxychloroquine effectiv ...... atic review and meta-analysis.

@en

P2093

Hong Hua

http://www.w3.org/2001/XMLSchema#string

Li-Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Pan Wei

http://www.w3.org/2001/XMLSchema#string

Shi-Qin Wang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

Meta-analysis in clinical trials

Epidemiology of Sjögren's Syndrome-from an Oral Perspective

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

Treatment of primary Sjögren syndrome.

Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial.

Antimalarials for rheumatoid arthritis.

Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development.

Cytokines in Sjogren's syndrome: potential therapeutic targets.

P2888

s12891-017-1543-z

P304

186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12891-017-1543-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2017-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085378630

http://www.w3.org/2001/XMLSchema#string

P698

28499370

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

Sjögren's syndrome

hydroxychloroquine

P932

5427554

http://www.w3.org/2001/XMLSchema#string